Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer

Dick Domanik

Status: Terminated

Conditions: Endometrial Cancer; Uterine Cancer

Treatments: Other: P2x7 assay

Study type: Interventional

Funder types: Industry

Identifiers

NCT00471120

13806-CC113

Details and patient eligibility

About

This study aims at developing an accurate, simple, and cost-effective method for screening and early detection of uterine cancers

Full description

The present study aims at developing an accurate, simple and cost-effective method for screening and early detection of uterine cancers in women using novel inventions and biotechnology methods for collection and assay of uterine cells. Results of P2X7 assays using tissues obtained from women with known uterine cancer and from women with histologically normal endometrium will be compared. These data will also serve as basis for future studies to test the predictive value of the method in population-based studies.

Enrollment: 20 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• women scheduled to undergo hysterectomy
• ages 18 years and older

Exclusion criteria

• pregnant women
• students or employees under the direct supervision on the investigators.

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

P2x7 Assay

Experimental group

Description:

Compare assay results with biopsy

Treatment:

Other: P2x7 assay